XENOBIOTICA, cilt.43, sa.3, ss.263-275, 2013 (SCI-Expanded, Scopus)
1. This study attempted to investigate the ability of microsomal NADH-cytochrome b5 reductase and cytochrome P450 2B4 to reductively activate idarubicin and mitomycin C.